Day: January 30, 2023

FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment

Keytruda (Pembrolizumab) | Lung Cancer
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with [...]